BIOAFFINITY TECHNOLOGIES INC
BIAFNASDAQ🏆 #3892 by market capEarnings Nov 12US Equity
$352.43▼ $18.71 (−5.31%)
Simulated price1h—
24h▼ 5.3%
7d—
14d—
30d—
1y—
🏦Market Cap
$4M
Small Cap
📈Revenue Growth (YoY)
-35.8%
Declining
📊Gross Margin
33.1%
Moderate
💵FCF Margin
—
⚖️P/S Ratio
0.5x
Cheap
Otter Score
45
Weak
No chart data available for BIAF.
Trading Snapshot
- Day Range
- $350.30 – $357.46
- 52-Week Range
- $0.49 – $13.50
- Volume
- $2.61B
- Avg Volume
- $1.90B
- Shares Outstanding
- 7.8M
- Next Earnings
- Sep 28, 2026
Fundamentals Snapshot
- Annual Revenue
- $7M
- Last Q Revenue
- $2M
- P/E Ratio
- —
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-11.32
- Dividend Yield
- —
Why Investors Own BIAF
- ✓High-growth profile — revenue up -5.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 48% gross margin and 27% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$7M▼ −9.5% YoY
Gross Margin (TTM)
48.0%▲ +1.2% YoY
Operating Income (TTM)
$2M▼ −9.5% YoY
Free Cash Flow (TTM)
$2M▼ −9.5% YoY
About BIOAFFINITY TECHNOLOGIES INC
A company profile for BIOAFFINITY TECHNOLOGIES INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
45/100
Analyst Price Target
ⓘAverage Target
$346.47
▼ −1.7% Downside
High Target$427.60
Low Target$257.49
Based on 18 analysts
Latest News & Updates
🚀
Reuters·2h ago
BIOAFFINITY TECHNOLOGIES INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift BIAF price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
BIOAFFINITY TECHNOLOGIES INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.